Stockscreener 앱 받기
39.78
0.08%
0.03
시간 외 거래:
39.78
전일 마감가:
$39.75
열려 있는:
$39.73
하루 거래량:
1.21M
Relative Volume:
0.48
시가총액:
$6.16B
수익:
$15.06M
순이익/손실:
$-250.69M
주가수익비율:
-22.41
EPS:
-1.7748
순현금흐름:
$-209.28M
1주 성능:
+0.20%
1개월 성능:
+0.79%
6개월 성능:
+37.27%
1년 성능:
+209.09%
1일 변동 폭
$39.73
$39.81
1주일 범위
$39.66
$39.85
52주 변동 폭
$10.95
$40.26
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
명칭
Centessa Pharmaceuticals Plc Adr
전화
44 7391 789784
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
39.78 | 6.15B | 15.06M | -250.69M | -209.28M | -1.7748 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2026-02-24 | 개시 | Wolfe Research | Outperform |
| 2025-12-10 | 재개 | Oppenheimer | Outperform |
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 개시 | Wells Fargo | Overweight |
| 2025-08-29 | 재개 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-05-08 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-07-18 | 개시 | Oppenheimer | Outperform |
| 2023-11-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-10-26 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 개시 | Evercore ISI | Outperform |
| 2023-06-12 | 개시 | Guggenheim | Buy |
| 2023-03-17 | 개시 | SVB Securities | Outperform |
| 2022-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-02-11 | 개시 | Goldman | Neutral |
모두보기
Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스
Eli Lilly, Centessa Pharmaceuticals receive US green light - MLex
HSR waiting period lapses for Centessa (CNTA) sale to Eli Lilly under UK scheme - Stock Titan
LLY to buy neuroscience biotech Centessa Pharmaceuticals in $7.8B deal - MSN
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plcCNTA - ChartMill
Centessa (NASDAQ: CNTA) to be acquired by Lilly for $38 plus up to $9 CVR - Stock Titan
Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After A 191% One Year Surge? - Yahoo Finance
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 - GlobeNewswire Inc.
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month HighStill a Buy? - MarketBeat
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN
Centessa (NASDAQ: CNTA) schedules 2026 AGM and advisory pay vote - Stock Titan
38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Short Interest Down 47.5% in April - MarketBeat
Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35 - marketscreener.com
Lilly to buy Centessa (NASDAQ: CNTA) for $38/ share plus $9 CVR - Stock Titan
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? - Finviz
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? - Sahm
Free cash flow per share of Centessa Pharmaceuticals PLC ADR – MUN:260 - TradingView
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Sahm
This Akamai Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next? - Defense World
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA) - Sahm
Centessa Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:CNTA) - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal - Yahoo Finance
JPMorgan Chase & Co. Sells 186,539 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
0.12%
자본화:
|
볼륨(24시간):